Oncocyte Corporation Shares Approach 52-Week Low - Market Mover
The shares closed 1.0% above its 52-week low of $2.02, with trading volume higher than its 30 day average
Dec 31, 2021 by Kwhen Finance Editors
Oncocyte Corporation (OCX) shares closed today at 1.0% above its 52 week low of $2.02, giving the company a market cap of $188M. The stock is currently down 14.6% year-to-date, down 16.0% over the past 12 months, and down 71.1% over the past five years. This week, the Dow Jones Industrial Average rose 2.1%, and the S&P 500 rose 2.1%.
Trading Activity
- Trading volume this week was 201.5% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 2.2.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Oncocyte Corporation | -2.4 | -14.6 | -16.0 | ||
| Dow Jones Industrial Average | -0.2 | 21.3 | 22.3 | 0.0 | 24.5 |
| S&P 500 Index | -0.3 | 29.4 | 30.3 | -0.2 | 32.8 |
| Health Care | 0.3 | 23.7 | 25.0 | 0.0 | 28.0 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 86.0%
- The company's stock price performance over the past 12 months lags the peer average by 137.2%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Oncocyte Corporation | OCX | 0 | -14.6 | -16.0 | ||
| Peer Avg | N/A | 0 | -7.9 | -6.8 | -26.1 | 30.7 |
| Ovid Therapeutics Inc | OVID | 0 | 36.4 | 38.2 | -34.4 | 38.8 |
| Otonomy Inc | OTIC | 0 | -67.9 | -65.2 | -69.9 | 84.2 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: